Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.45 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopulegol SCHEMBL8814498 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| Isopulegol SCHEMBL8816208 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| Isopulegol SCHEMBL8818931 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| Isopulegol SCHEMBL18828953 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| Isopulegol SCHEMBL15013625 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| Isopulegol SCHEMBL5043480 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| Isopulegol SCHEMBL20903638 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| Isopulegol SCHEMBL20903648 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| Isopulegol SCHEMBL20681722 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| Isopulegol SCHEMBL8618394 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230202996-A1 | SYNTHETIC METHODS FOR MAKING CARBOXYLIC ACIDS, ESTERS AND LACTONES | P2 SCIENCE, INC. | 2023-06-29 | — | — | US | disclosed |
| EP-4112727-A2 | METHOD FOR THE BIOCATALYTIC CYCLISATION OF TERPENES AND CYCLASE MUTANTS WHICH CAN BE USED IN SAME | BASF SE (DE) | 2023-01-04 | — | — | EP | disclosed |
| US-10568852-B2 | Combination compositions and their use in methods for treating obesity and obesity-related disorders | HELMHOLTZ ZENTRUM MUNCHEN - DEUTSCHES FORSCHUNGSZENTRUM FUR GESUNDHEIT UND UMWELT (GMBH) (DE) | 2020-02-25 | — | — | US | disclosed |
| EP-3470515-A2 | METHOD FOR THE BIOCATALYTIC CYCLISATION OF TERPENES AND CYCLASE MUTANTS WHICH CAN BE USED IN SAME | BASF SE (DE) | 2019-04-17 | — | — | EP | disclosed |
| US-9988331-B2 | Method for producing optically active, racemic menthol | BASF SE (DE) | 2018-06-05 | — | — | US | disclosed |
| US-9988331-B2 | Method for producing optically active, racemic menthol | BASF SE (DE) | 2018-06-05 | — | — | US | disclosed |
| US-20180147163-A1 | COMBINATION COMPOSITIONS AND THEIR USE IN METHODS FOR TREATING OBESITY AND OBESITY-RELATED DISORDERS | HELMHOLTZ ZENTRUM MUNCHEN - DEUTSCHES FORSCHUNGSZENTRUM FUR GESUNDHEIT UND UMWELT (GMBH) (DE) | 2018-05-31 | — | — | US | disclosed |
| US-9975837-B2 | Method for synthesizing optically active carbonyl compounds | BASF SE (DE) | 2018-05-22 | — | — | US | disclosed |
| US-20180057437-A1 | METHOD FOR SYNTHESIZING OPTICALLY ACTIVE CARBONYL COMPOUNDS | BASF SE (DE) | 2018-03-01 | — | — | US | disclosed |
| EP-2139835-B1 | METHOD FOR SYNTHESIZING OPTICALLY ACTIVE CARBONYL COMPOUNDS | BASF SE (DE) | 2017-05-10 | — | — | EP | disclosed |
| US-20080214877-A1 | Method for the Production of Enriched Isopulegol | BASF SE (DE) | 2008-09-04 | — | — | US | disclosed |
| US-20080214877-A1 | Method for the Production of Enriched Isopulegol | BASF SE (DE) | 2008-09-04 | — | — | US | disclosed |
| US-20080207957-A1 | Method For The Production Of Isopulegol | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-28 | — | — | US | disclosed |
| US-20080207957-A1 | Method For The Production Of Isopulegol | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-28 | — | — | US | disclosed |
| US-20080167504-A1 | reacting a bis(diarylphenol) ligand with an alkylaluminum compound and/or a complex aluminum hydride; producing isopulegol by cyclization of citronellal in the presence of diarylphenoxyaluminum compounds as catalysts | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-10 | — | — | US | disclosed |
| US-20080167504-A1 | reacting a bis(diarylphenol) ligand with an alkylaluminum compound and/or a complex aluminum hydride; producing isopulegol by cyclization of citronellal in the presence of diarylphenoxyaluminum compounds as catalysts | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-10 | — | — | US | disclosed |
| EP-1942111-A1 | Diarylphenoxy aluminum compounds | BASF SE (DE) | 2008-07-09 | — | — | EP | disclosed |
| US-20080139852-A1 | Method For The Production Of Menthol | BASF AKTIENGESELLSCHAFT (DE) | 2008-06-12 | — | — | US | disclosed |
| US-20080139852-A1 | Method For The Production Of Menthol | BASF AKTIENGESELLSCHAFT (DE) | 2008-06-12 | — | — | US | disclosed |
| WO-2007023109-A1 | METHOD FOR THE PRODUCTION OF ENRICHED ISOPULEGOL | BASF SE (DE) | 2007-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10568852-B2 | Combination compositions and their use in methods for treating obesity and obesity-related disorders | FABP4, LIPC, GPR119 | TRPA1 4084/4885TRPM8 4125/4885CA1 2991/4885 |
| US-20080167504-A1 | reacting a bis(diarylphenol) ligand with an alkylaluminum compound and/or a complex aluminum hydride; producing isopulegol by cyclization of citronellal in the presence of diarylphenoxyaluminum compounds as catalysts | ACSL3, ACSL1, ACSL5 | TRPA1 42/4885TRPM8 69/4885CA1 120/4885 |
| US-20180147163-A1 | COMBINATION COMPOSITIONS AND THEIR USE IN METHODS FOR TREATING OBESITY AND OBESITY-RELATED DISORDERS | FABP4, LIPC, GPR119 | TRPA1 4084/4885TRPM8 4125/4885CA1 2991/4885 |
| US-20230202996-A1 | SYNTHETIC METHODS FOR MAKING CARBOXYLIC ACIDS, ESTERS AND LACTONES | FDFT1, DLST, PCMT1 | TRPA1 677/4885TRPM8 1032/4885CA1 655/4885 |
| US-20080207957-A1 | Method For The Production Of Isopulegol | ACSL3, ACSL6, ACSL1 | TRPA1 1370/4885TRPM8 4317/4885CA1 37/4885 |
| US-20080139852-A1 | Method For The Production Of Menthol | NISCH, CYP8B1, MSMO1 | TRPA1 419/4885TRPM8 300/4885CA1 1527/4885 |
| US-20180057437-A1 | METHOD FOR SYNTHESIZING OPTICALLY ACTIVE CARBONYL COMPOUNDS | CBR3, CBR1, HRH4 | TRPA1 1176/4885TRPM8 2327/4885CA1 493/4885 |
| US-20080214877-A1 | Method for the Production of Enriched Isopulegol | MSMO1, IPO5, SQLE | TRPA1 1158/4885TRPM8 548/4885CA1 1557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.